ENFOQIS Trademark

Trademark Overview

On Monday, February 3, 2020, a trademark application was filed for ENFOQIS with the United States Patent and Trademark Office. The USPTO has given the ENFOQIS trademark a serial number of 88783014. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 8, 2024. This trademark is owned by Cingulate Therapeutics LLC. The ENFOQIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of attention deficit hyperactivity disorder (ADHD)
enfoqis

General Information

Serial Number88783014
Word MarkENFOQIS
Filing DateMonday, February 3, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 8, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 5, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of attention deficit hyperactivity disorder (ADHD)

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 6, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCingulate Therapeutics LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressKansas City, KS 66205
Party NameCingulate Therapeutics LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressKansas City, KS 66205

Trademark Events

Event DateEvent Description
Monday, April 8, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 8, 2024ABANDONMENT - NO USE STATEMENT FILED
Friday, September 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 7, 2023SOU EXTENSION 5 GRANTED
Monday, August 28, 2023SOU EXTENSION 5 FILED
Thursday, September 7, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 28, 2023SOU TEAS EXTENSION RECEIVED
Thursday, February 16, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 14, 2023SOU EXTENSION 4 GRANTED
Tuesday, February 14, 2023SOU EXTENSION 4 FILED
Tuesday, February 14, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, January 17, 2023ASSIGNED TO EXAMINER
Thursday, August 25, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 23, 2022SOU EXTENSION 3 GRANTED
Tuesday, August 23, 2022SOU EXTENSION 3 FILED
Tuesday, August 23, 2022SOU TEAS EXTENSION RECEIVED
Thursday, February 24, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 22, 2022SOU EXTENSION 2 GRANTED
Tuesday, February 22, 2022SOU EXTENSION 2 FILED
Tuesday, February 22, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, July 20, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 20, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 20, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 8, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 4, 2021SOU EXTENSION 1 GRANTED
Friday, June 4, 2021SOU EXTENSION 1 FILED
Friday, June 4, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, March 2, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 5, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 5, 2021PUBLISHED FOR OPPOSITION
Wednesday, December 16, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 2, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 23, 2020SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, November 23, 2020ASSIGNED TO LIE
Tuesday, April 21, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, April 21, 2020LETTER OF SUSPENSION E-MAILED
Tuesday, April 21, 2020SUSPENSION LETTER WRITTEN
Tuesday, April 21, 2020EXAMINER'S AMENDMENT ENTERED
Tuesday, April 21, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, April 21, 2020EXAMINERS AMENDMENT E-MAILED
Tuesday, April 21, 2020EXAMINERS AMENDMENT -WRITTEN
Monday, April 20, 2020ASSIGNED TO EXAMINER
Thursday, February 6, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 6, 2020NEW APPLICATION ENTERED

Related Keywords

enfoqis hyperactivity disorder adhd deficit attention preparations treatment pharmaceutical